-
1 month ago | 
auntminnie.com | Will Morton |Amerigo Allegretto |Liz Carey |Erik Anderson
Lunit has signed a five-year contract with healthcare network Abu Dhabi Health Services Company (SEHA) to deploy Lunit’s AI-based Insight MMG mammography analysis software across SEHA’s network of hospitals and clinics. The agreement follows a successful proof-of-concept evaluation initiated in 2022, the company said.
-
1 month ago | 
auntminnie.com | Will Morton |Amerigo Allegretto |Liz Carey |Erik Anderson
Lunit is highlighting results published March 10 in Nature Communications that validate the effectiveness of its Lunit Insight MMG in South Korea's national breast cancer screening program. The study was led by Yun-Woo Chang, MD, from Soonchunhyang University Seoul Hospital in collaboration with breast and general radiologists from six South Korean academic hospitals.
-
1 month ago | 
auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown
AI software developer iCAD and PACS vendor RamSoft have entered a preferred distributor and integration partnership. Under the agreement, RamSoft will integrate iCAD's ProFound AI Breast Health Suite in its PowerServer RIS/PACS software, which is used by more than 750 imaging centers worldwide, the companies said. iCAD’s technology is based on data from a woman's 2D digital screening mammogram and is designed to help detect cancers in between screening intervals, according to the company.
-
1 month ago | 
auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown
Lunit subsidiary Volpara Health's volumetric breast density assessment has been integrated into the newly released version of the BOADICEA (also known as CanRisk) breast cancer risk model. Studies have shown the use of Volpara density in BOADICEA to improve model accuracy compared with using BI-RADS density categories, the company said. Volpara also reported that it has inked an agreement with Optellum, an AI lung cancer diagnosis developer.
-
1 month ago | 
auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown
Outpatient medical imaging provider SimonMed Imaging has implemented MagView's Luminary Risk risk assessment software into its Personalized Breast Cancer Detection program. Luminary Risk helps users identify women who may need additional screening beyond a standard mammogram, and consists of a patient history collection platform that highlights actionable risk scores, patient recommendations, and care plans, SimonMed said.
-
2 months ago | 
auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto
Susan G. Komen urged quick passage of legislation introduced in Pennsylvania to eliminate out-of-pocket costs for women for necessary diagnostic breast cancer imaging. “Nobody should be forced to skip medical care that helps to detect breast cancer early because of the cost, yet thousands of Pennsylvanians are forced to make that decision every year,” noted Molly Guthrie, vice president of policy and advocacy at Susan G. Komen, in a news release. HB 433 was introduced by Rep.
-
Jan 22, 2025 | 
auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto
Hologic has received a warning letter from the U.S. Food and Drug Administration (FDA) for not addressing violations related to the company’s BioZorb 3D bioabsorbable radiographic markers. The letter follows a previous warning by the FDA to consumers, healthcare providers, and healthcare facilities not to use the markers as well as a voluntary recall by Hologic, both issued in October. To date, 252 injuries related to the markers have been reported.
-
Jan 22, 2025 | 
auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto
Siemens Healthineers has installed the first Mammomat B.brilliant mammography system in the U.S. at an imaging center in Iowa run by Grace Breast Imaging & Medical Spa. Mammomat B.brilliant is the first completely redesigned mammography system by Siemens in over a decade, the company noted.
-
Jan 8, 2025 | 
auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto
ScreenPoint Medical has acquired Biomediq, a Danish research-based company, after a decade of close collaboration on image-based breast cancer risk assessment. Biomediq has developed breast cancer risk analysis technology that enables automatic, computer-based analysis of 2D and 3D mammograms for analysis of future risk of breast cancer.
-
Nov 25, 2024 | 
auntminnie.com | Erik Anderson |Dana Brown |Amerigo Allegretto |Will Morton
Densitas plans to collaborate with the American College of Radiology (ACR) Learning Network on the network's quality improvement goals for mammography. The network supports improvement in imaging practices, Densitas said. It includes the ACR's ImPower Program, which is intended to standardize mammography imaging, specifically positioning.
